M&T Bank Corp Intra Cellular Therapies, Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 6,163 shares of ITCI stock, worth $512,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,163

Previous 6,163 -0.0%

Holding current value

$512,206

Previous $450,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$67.99 - $80.84 $111,639 - $132,739	1,642 Added 36.32%	6,163 $450,000
Q2 2024 Jul 31, 2024	BUY	$64.76 - $79.84 $7,965 - $9,820	123 Added 2.8%	4,521 $309,000
Q1 2024 May 07, 2024	SELL	$64.37 - $75.65 $24,589 - $28,898	-382 Reduced 7.99%	4,398 $304,000
Q4 2023 Feb 06, 2024	BUY	$46.37 - $73.65 $35,890 - $57,005	774 Added 19.32%	4,780 $342,000
Q3 2023 Nov 02, 2023	SELL	$52.09 - $64.1 $60,841 - $74,868	-1,168 Reduced 22.57%	4,006 $208,000
Q2 2023 Aug 09, 2023	SELL	$54.67 - $66.44 $25,640 - $31,160	-469 Reduced 8.31%	5,174 $327,000
Q1 2023 May 11, 2023	SELL	$43.8 - $56.99 $25,185 - $32,769	-575 Reduced 9.25%	5,643 $305,000
Q4 2022 Feb 13, 2023	SELL	$44.07 - $54.45 $146,797 - $181,372	-3,331 Reduced 34.88%	6,218 $329,000
Q4 2022 Feb 13, 2023	BUY	$44.07 - $54.45 $161,340 - $199,341	3,661 Added 62.18%	9,549 $505,000
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $93,769 - $131,738	2,196 Added 59.48%	5,888 $274,000
Q2 2022 Aug 05, 2022	SELL	$43.0 - $65.64 $67,080 - $102,398	-1,560 Reduced 29.7%	3,692 $211,000
Q1 2022 May 09, 2022	SELL	$38.74 - $62.09 $60,124 - $96,363	-1,552 Reduced 22.81%	5,252 $322,000
Q4 2021 Feb 07, 2022	BUY	$35.2 - $53.42 $2,886 - $4,380	82 Added 1.22%	6,804 $356,000
Q3 2021 Oct 28, 2021	SELL	$28.72 - $42.49 $15,767 - $23,327	-549 Reduced 7.55%	6,722 $251,000
Q2 2021 Aug 13, 2021	BUY	$29.3 - $44.5 $7,500 - $11,392	256 Added 3.65%	7,271 $297,000
Q1 2021 May 06, 2021	SELL	$30.8 - $39.51 $121,290 - $155,590	-3,938 Reduced 35.95%	7,015 $239,000
Q4 2020 Feb 12, 2021	SELL	$23.34 - $32.22 $215,264 - $297,165	-9,223 Reduced 45.71%	10,953 $348,000
Q3 2020 Nov 06, 2020	BUY	$17.61 - $31.86 $54,080 - $97,842	3,071 Added 17.95%	20,176 $518,000
Q2 2020 Jul 29, 2020	BUY	$14.35 - $26.64 $77,045 - $143,030	5,369 Added 45.75%	17,105 $439,000
Q1 2020 May 14, 2020	BUY	$12.31 - $33.12 $144,470 - $388,696	11,736 New	11,736 $180,000

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account